Management of Isotretinoin-Induced Nail Toxicity

Dose Modification and Treatment Continuation

The American Academy of Dermatology recommends reducing the isotretinoin dose by 50% or more if the patient is on standard dosing, and restarting at a lower dose (0.25-0.4 mg/kg/day) after nail improvement, as low-dose isotretinoin remains effective for moderate acne with fewer adverse effects 1
For patients with moderate acne and isolated median dystrophy, switching to low-dose isotretinoin (0.25-0.4 mg/kg/day) maintains efficacy with significantly fewer adverse effects 1
Consider stopping treatment if the patient has achieved adequate cumulative dosing (approaching 120 mg/kg) and acne has significantly improved, as the therapeutic benefit plateaus beyond 150 mg/kg 1

Apply moisturizing creams or ointments to the nail folds and cuticles twice daily to prevent xerosis, and consider urea-containing moisturizers (5-10% concentration) for enhanced hydration of the nail unit 2

Patients on isotretinoin have higher rates of Staphylococcus aureus colonization, increasing the risk of secondary paronychia if the dystrophic nail allows bacterial entry 3